Home » SEC Filing Articles
Atour Lifestyle Holdings Limited Sponsored ADR $ATAT Shares Sold by Aspex Management HK Ltd
Aspex Management HK Ltd reduced its position in Atour Lifestyle Holdings Limited Sponsored ADR (NASDAQ:ATAT – Free Report) by 16.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities... More of this article »
Aspex Management HK Ltd Invests $53.51 Million in Lam Research Corporation $LRCX
Aspex Management HK Ltd acquired a new position in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired... More of this article »
368,351 Shares in Baidu, Inc. $BIDU Purchased by Aspex Management HK Ltd
Aspex Management HK Ltd acquired a new stake in Baidu, Inc. (NASDAQ:BIDU – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 368,351 shares of the... More of this article »
Atlas Merchant Capital LLC Has $223.71 Million Stock Position in Circle Internet Group, Inc. $CRCL
Atlas Merchant Capital LLC reduced its holdings in shares of Circle Internet Group, Inc. (NYSE:CRCL – Free Report) by 5.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and... More of this article »
Atlas Venture Life Science Advisors LLC Has $141.58 Million Stock Position in Disc Medicine, Inc. $IRON
Atlas Venture Life Science Advisors LLC cut its stake in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 10.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor... More of this article »
Kymera Therapeutics, Inc. $KYMR Stock Position Lessened by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC reduced its stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 3.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Avoro Capital Advisors LLC Purchases 117,777 Shares of Krystal Biotech, Inc. $KRYS
Avoro Capital Advisors LLC increased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 4.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Avoro Capital Advisors LLC Has $730.18 Million Holdings in argenex SE $ARGX
Avoro Capital Advisors LLC lessened its position in argenex SE (NASDAQ:ARGX – Free Report) by 15.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor... More of this article »
Atlas Venture Life Science Advisors LLC Buys New Position in ImageneBio, Inc. $IMA
Atlas Venture Life Science Advisors LLC bought a new position in shares of ImageneBio, Inc. (NASDAQ:IMA – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and... More of this article »
Avoro Capital Advisors LLC Has $1.02 Billion Stock Holdings in Ascendis Pharma A/S $ASND
Avoro Capital Advisors LLC lifted its position in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 2.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund... More of this article »
Aspex Management HK Ltd Reduces Holdings in RLX Technology Inc. Sponsored ADR $RLX
Aspex Management HK Ltd lowered its stake in RLX Technology Inc. Sponsored ADR (NYSE:RLX – Free Report) by 34.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor... More of this article »
Sionna Therapeutics, Inc. $SION Shares Sold by Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC lowered its stake in Sionna Therapeutics, Inc. (NASDAQ:SION – Free Report) by 2.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
Avoro Capital Advisors LLC Cuts Holdings in Madrigal Pharmaceuticals, Inc. $MDGL
Avoro Capital Advisors LLC decreased its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 2.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
Avoro Capital Advisors LLC Has $375.94 Million Position in Arrowhead Pharmaceuticals, Inc. $ARWR
Avoro Capital Advisors LLC lifted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.... More of this article »
Avoro Capital Advisors LLC Buys 5,808,080 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
Avoro Capital Advisors LLC increased its stake in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA – Free Report) by 116.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm... More of this article »
2Xideas AG Sells 12,419 Shares of IQVIA Holdings Inc. $IQV
2Xideas AG cut its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 19.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,475 shares... More of this article »
Brookfield Asset Management Ltd. $BAM is 2Xideas AG’s 9th Largest Position
2Xideas AG increased its stake in shares of Brookfield Asset Management Ltd. (NYSE:BAM – Free Report) (TSE:BAM.A) by 8.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional... More of this article »
Ryan Specialty Holdings Inc. $RYAN Shares Sold by 2Xideas AG
2Xideas AG reduced its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 14.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.... More of this article »
2Xideas AG Sells 36,165 Shares of CoStar Group, Inc. $CSGP
2Xideas AG decreased its position in shares of CoStar Group, Inc. (NASDAQ:CSGP – Free Report) by 22.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission... More of this article »
2Xideas AG Has $42.44 Million Holdings in Fortinet, Inc. $FTNT
2Xideas AG grew its stake in Fortinet, Inc. (NASDAQ:FTNT – Free Report) by 4.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor... More of this article »
Edwards Lifesciences Corporation $EW Stake Cut by 2Xideas AG
2Xideas AG trimmed its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 486,257 shares of the medical research... More of this article »
PTC Inc. $PTC Stake Decreased by 2Xideas AG
2Xideas AG lessened its position in PTC Inc. (NASDAQ:PTC – Free Report) by 20.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 209,680... More of this article »
2Xideas AG Acquires 8,397 Shares of ResMed Inc. $RMD
2Xideas AG lifted its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 11.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional... More of this article »
2Xideas AG Sells 11,074 Shares of Autodesk, Inc. $ADSK
2Xideas AG decreased its holdings in shares of Autodesk, Inc. (NASDAQ:ADSK – Free Report) by 20.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
2Xideas AG Has $44.54 Million Position in Intercontinental Exchange Inc. $ICE
2Xideas AG trimmed its holdings in Intercontinental Exchange Inc. (NYSE:ICE – Free Report) by 6.3% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 264,349 shares of the financial... More of this article »
Avoro Capital Advisors LLC Trims Position in Alkermes plc $ALKS
Avoro Capital Advisors LLC reduced its holdings in Alkermes plc (NASDAQ:ALKS – Free Report) by 22.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned... More of this article »
Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD
Avoro Capital Advisors LLC reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 16.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.... More of this article »
2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC acquired a new position in shares of Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission... More of this article »
Avoro Capital Advisors LLC Makes New Investment in Oruka Therapeutics, Inc. $ORKA
Avoro Capital Advisors LLC purchased a new stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,333,340 shares... More of this article »
Avoro Capital Advisors LLC Cuts Stock Position in MoonLake Immunotherapeutics $MLTX
Avoro Capital Advisors LLC lessened its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 51.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and... More of this article »
Avoro Capital Advisors LLC Takes $4.58 Million Position in Tango Therapeutics, Inc. $TNGX
Avoro Capital Advisors LLC acquired a new stake in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Avoro Capital Advisors LLC Trims Stock Position in BioCryst Pharmaceuticals, Inc. $BCRX
Avoro Capital Advisors LLC reduced its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 72.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange... More of this article »
Bank of Hawaii Increases Position in Vanguard Growth ETF $VUG
Bank of Hawaii grew its stake in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 5.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 340,774 shares of... More of this article »
iShares Core S&P 500 ETF $IVV Stock Holdings Trimmed by Bank of Hawaii
Bank of Hawaii decreased its position in iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 0.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.... More of this article »
ADMA Biologics Inc $ADMA Shares Bought by B Group Inc.
B Group Inc. grew its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,412,542... More of this article »
Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc.
B Group Inc. trimmed its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 10.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Ultragenyx Pharmaceutical Inc. $RARE Shares Sold by B Group Inc.
B Group Inc. reduced its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 24.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The... More of this article »
Spyre Therapeutics, Inc. $SYRE Shares Bought by B Group Inc.
B Group Inc. increased its holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 25.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 100,000 shares of the company’s... More of this article »
Vanguard Value ETF $VTV Shares Sold by Bank of Hawaii
Bank of Hawaii lowered its stake in Vanguard Value ETF (NYSEARCA:VTV – Free Report) by 1.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional... More of this article »
Bank of Hawaii Sells 16,828 Shares of Vanguard High Dividend Yield ETF $VYM
Bank of Hawaii lessened its position in Vanguard High Dividend Yield ETF (NYSEARCA:VYM – Free Report) by 7.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission... More of this article »
Bank of Hawaii Buys 11,427 Shares of Vanguard Total Bond Market ETF $BND
Bank of Hawaii grew its stake in Vanguard Total Bond Market ETF (NASDAQ:BND – Free Report) by 5.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Bank of Hawaii Sells 298,942 Shares of Vanguard Tax-Exempt Bond ETF $VTEB
Bank of Hawaii decreased its position in shares of Vanguard Tax-Exempt Bond ETF (NYSEARCA:VTEB – Free Report) by 54.0% during the third quarter, according to the company in its most recent filing with the SEC. The institutional... More of this article »
Bank of Hawaii Reduces Stock Holdings in Johnson & Johnson $JNJ
Bank of Hawaii decreased its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The... More of this article »
Bank of Hawaii Sells 3,585 Shares of AbbVie Inc. $ABBV
Bank of Hawaii reduced its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm... More of this article »
NRG Energy, Inc. $NRG Holdings Decreased by Bank of Hawaii
Bank of Hawaii reduced its holdings in NRG Energy, Inc. (NYSE:NRG – Free Report) by 19.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional... More of this article »
Vanguard Short-Term Bond ETF $BSV Shares Purchased by Bank of Hawaii
Bank of Hawaii increased its stake in shares of Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 19.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional... More of this article »
Natera, Inc. $NTRA Position Reduced by Bank of Hawaii
Bank of Hawaii reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 18.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The... More of this article »
97,246 Shares in Vanguard Long-Term Treasury ETF $VGLT Acquired by Bank of Hawaii
Bank of Hawaii purchased a new position in Vanguard Long-Term Treasury ETF (NASDAQ:VGLT – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.... More of this article »